Opendata, web and dolomites

ILO SIGNED

Innovative dual cycle tracking system for contraception and conception on a single device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ILO project word cloud

Explore the words cloud of the ILO project. It provides you a very rough idea of what is the project "ILO" about.

opportunity    usually    facts    child    business    track    natural    cumulative    core    23    proven    body    180    progression    monitoring    stress    700    contraceptive    2016    relying    air    conveys    criteria    irregular    levels    predicts    sell    thanks    stage    influencing    fertile    measuring    accuracy    combination    algorithms    cycle    menstrual    rely    lack    invasive    temperature    limitations    golden    500    women    billion    period    bleeding    device    app    valued    overcome    pregnant    edge    variables    count    dual    reliably    accurate    back    staff    2023    health    units    fulfils    hence    manner    profits    carbomed    periods    co2    initially    scientifically    million    exhaled    contraception    subsequently    wish    approached    handheld    seamlessly    market    tool    fashioned    expertise    self    conceiving    precise    first    17    amount    fairly    commercialization    bespoke    cutting    length    none    window    innovative    time    39    ilo    subjective    strive    predicting    reaching    chances    tracking    ovulation   

Project "ILO" data sheet

The following table provides information about the project.

Coordinator
CARBOMED MEDICAL SOLUTIONS GMBH & CO KG 

Organization address
address: NEUE STIFTINGTALSTRASSE 2/5 OG
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.iloveovulation.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARBOMED MEDICAL SOLUTIONS GMBH & CO KG AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

Women usually track their menstrual cycle for three main reasons: As a natural contraceptive tool, to increase the chances of conceiving or for health-related reasons. However, monitoring every stage of the cycle in an accurate manner has proven challenging, due to the many variables influencing its progression (e.g. irregular periods, stress, etc.). Currently, there are two main approached to cycle tracking: Cycle tracking devices (which represent the old-fashioned approach, fairly reliable but require self-assessment and expertise to get accuracy), and “cutting edge” app-based cycle tracking methods (which are user-friendly, but rely in subjective facts related to the period - e.g. length or amount of bleeding-, traditional measurements -e.g. core body temperature- and algorithms, and lack accuracy. Hence, none of these approaches fulfils the “golden” criteria of being reliable, precise, simple and non-invasive. At Carbomed, we strive to overcome the limitations of both approaches thanks to our innovative ILO system, the seamlessly combination of a handheld device and an app, that reliably predicts the time of ovulation by relying on a scientifically-based method: Measuring the CO2 levels from exhaled air. ILO conveys the best features from both approaches, being accurate, simple and non-invasive while providing a user-friendly experience thanks to our bespoke app. ILO can be used as a dual cycle tracking device predicting the most fertile window, as a natural contraceptive method, but also as a tracking device for those who want to get pregnant. For Carbomed, ILO represents a large business opportunity, aimed initially at the child wish market and subsequently (and most importantly) at the contraception market valued at €17.6 billion back in 2016. In this way, we expect to sell 180,500 ILO units in the first three years of commercialization, reaching cumulative profits of €23.39 million by 2023. To reach this goal, we will increase our staff count by 700%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ILO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ILO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

LiCrete (2018)

LiCrete - Light transmitting composite material for building purposes

Read More